31
Views
0
CrossRef citations to date
0
Altmetric
Correspondence

The safety of obesity drugs – correspondence

Response to: GREENWAY FL, CARUSO MK: Safety of obesity drugs. Expert Opin. Drug Saf. (2005) 4(6):1083-1095.

, &
Pages 475-476 | Published online: 18 Sep 2007
 

Conflict of interest

Professors Van Gaal, Scheen and Formiguera have received consultancy fees and honoraria from sanofi-aventis in relation to their clinical work with rimonabant. The RIO trial program was funded by sanofi-aventis.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 752.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.